CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography
- PMID: 31326488
- DOI: 10.1016/j.jcmg.2019.04.023
CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography
Abstract
Objectives: This study sought to determine whether cardiac magnetic resonance (CMR) may identify structural heart disease (SHD) in patients with ventricular arrhythmia who had echocardiography ruled out pathological findings.
Background: Approximately one-half of sudden cardiac deaths are attributable to malignant VA. Echocardiography is commonly used to identify SHD that is the most frequent substrate of VA.
Methods: A single-center prospective study was conducted in consecutive patients with significant VA, categorized as >1,000 but <10,000 ventricular ectopic beats [VEBs]/24 h; ≥10,000 VEBs/24 h; nonsustained ventricular tachycardia, sustained ventricular tachycardia, or a history of resuscitated cardiac arrest, and no pathological findings at echocardiography, requiring a clinically indicated CMR. Primary endpoint was CMR detection of SHD. Secondary endpoints were a composite of CMR detection of SHD and abnormal findings not specific for a definite SHD diagnosis.
Results: A total of 946 patients were enrolled (mean 41 ± 16 years of age; 64% men). CMR studies were used to diagnose SHD in 241 patients (25.5%) and abnormal findings not specific for a definite SHD diagnosis in 187 patients (19.7%). Myocarditis (n = 91) was the more frequent disease, followed by arrhythmogenic cardiomyopathy (n = 55), dilated cardiomyopathy (n = 39), ischemic heart disease (n = 22), hypertrophic cardiomyopathy (n = 13), congenital cardiac disease (n = 10), left ventricle noncompaction (n = 5), and pericarditis (n = 5). The strongest univariate and multivariate predictors of SHD on CMR images were chest pain (odds ratios [OR]: 2.52 and 2.38, respectively) and sustained ventricular tachycardia (ORs: 2.67 and 2.23, respectively).
Conclusions: SHD was able to be identified on CMR imaging in a sizable number of patients with significant VA and completely normal echocardiography. Chest pain and sustained ventricular tachycardia were the strongest predictors of positive CMR imaging results.
Keywords: additional diagnostic value; arrhythmic substrate; cardiac magnetic resonance; cardiomyopathy; late gadolinium enhancement; myocarditis; prognosis; ventricular arrhythmia.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Routine Use of Cardiovascular Magnetic Resonance in the Work-Up of Patients With Ventricular Arrhythmias?JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 1):422-424. doi: 10.1016/j.jcmg.2019.10.006. Epub 2020 Jan 15. JACC Cardiovasc Imaging. 2020. PMID: 31954638 No abstract available.
-
Substrate for Ventricular Arrhythmia: To See Is to Know?JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 1):532-534. doi: 10.1016/j.jcmg.2020.01.002. JACC Cardiovasc Imaging. 2020. PMID: 32029195 No abstract available.
Similar articles
-
High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia.Europace. 2018 Sep 1;20(FI2):f179-f191. doi: 10.1093/europace/eux278. Europace. 2018. PMID: 29069369 Free PMC article.
-
Predictors of Left Ventricular Scar Using Cardiac Magnetic Resonance in Athletes With Apparently Idiopathic Ventricular Arrhythmias.J Am Heart Assoc. 2021 Jan 5;10(1):e018206. doi: 10.1161/JAHA.120.018206. Epub 2020 Dec 31. J Am Heart Assoc. 2021. PMID: 33381977 Free PMC article.
-
Cardiac magnetic resonance reveals concealed structural heart disease in patients with frequent premature ventricular contractions and normal echocardiography: A systematic review.Int J Cardiol. 2024 Oct 1;412:132306. doi: 10.1016/j.ijcard.2024.132306. Epub 2024 Jun 29. Int J Cardiol. 2024. PMID: 38950789
-
Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.Circ Cardiovasc Imaging. 2016 Oct;9(10):e004956. doi: 10.1161/CIRCIMAGING.115.004956. Circ Cardiovasc Imaging. 2016. PMID: 27729359
-
Cardiac magnetic resonance for ventricular arrhythmias: a systematic review and meta-analysis.Heart. 2024 Aug 26;110(18):1113-1123. doi: 10.1136/heartjnl-2024-324182. Heart. 2024. PMID: 39084706
Cited by
-
Cardiac Magnetic Resonance Imaging for Nonischemic Cardiac Disease in Out-of-Hospital Cardiac Arrest Survivors Treated with Targeted Temperature Management: A Multicenter Retrospective Analysis.J Clin Med. 2021 Feb 16;10(4):794. doi: 10.3390/jcm10040794. J Clin Med. 2021. PMID: 33669339 Free PMC article.
-
State-of-the-Art Multimodality Imaging in Sudden Cardiac Arrest with Focus on Idiopathic Ventricular Fibrillation: A Review.J Clin Med. 2022 Aug 10;11(16):4680. doi: 10.3390/jcm11164680. J Clin Med. 2022. PMID: 36012918 Free PMC article. Review.
-
Electrocardiographic characteristics of right-bundle-branch-block premature ventricular complexes predicting absence of left ventricular scar in athletes with apparently structural normal heart.Europace. 2023 Jul 4;25(7):euad217. doi: 10.1093/europace/euad217. Europace. 2023. PMID: 37466354 Free PMC article.
-
Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives.J Clin Med. 2021 Aug 20;10(16):3696. doi: 10.3390/jcm10163696. J Clin Med. 2021. PMID: 34441994 Free PMC article. Review.
-
Effect of Flecainide in Idiopathic Premature Ventricular Contractions and the Induced Cardiomyopathy-UNIFLECA: A Single Arm, Non-Randomized Trial: Review of the Literature and Initial Results.J Pers Med. 2025 Mar 29;15(4):132. doi: 10.3390/jpm15040132. J Pers Med. 2025. PMID: 40278311 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical